tiprankstipranks
Advertisement
Advertisement
DiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks
PremiumCompany AnnouncementsDiaMedica Therapeutics Highlights Clinical Gains Amid Trial Risks
2M ago
DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update
Premium
Company Announcements
DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update
2M ago
DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)
Premium
The Fly
DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)
2M ago
DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
PremiumThe FlyDiaMedica Therapeutics named a Top Idea for 2026 at Lake Street
5M ago
DiaMedica Therapeutics provides DM199 update following FDA meeting
Premium
The Fly
DiaMedica Therapeutics provides DM199 update following FDA meeting
6M ago
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
Premium
Company Announcements
DiaMedica Advances DM199 Preeclampsia Program After FDA Pre-IND Meeting
6M ago
DiaMedica Therapeutics Reports Q3 2025 Financial Results
PremiumCompany AnnouncementsDiaMedica Therapeutics Reports Q3 2025 Financial Results
7M ago
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
Premium
Company Announcements
DiaMedica Therapeutics’ Earnings Call: Mixed Outlook
7M ago
DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress
Premium
Company Announcements
DiaMedica Therapeutics Reports Q3 2025 Financial Results and Clinical Progress
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100